Drug-induced arrhythmias

被引:47
|
作者
Barnes, Brian J. [1 ]
Hollands, James M. [2 ]
机构
[1] Univ Kansas, Med Ctr, Sch Pharm, Kansas City, KS 66103 USA
[2] Barnes Jewish Hosp, Dept Pharm, St Louis, MO 63110 USA
关键词
drug-induced; arrhythmias; risk factors; QT interval; antiarrhythmics; inotropes; digoxin; electrolyte imbalances; anesthetic agents; bronchodilators; patient safety; LONG-QT SYNDROME; VOLATILE ANESTHETICS; HEART-FAILURE; ELECTROCARDIOGRAPHIC MANIFESTATIONS; VENTRICULAR-ARRHYTHMIAS; INTRAVENOUS MILRINONE; MYOCARDIAL-INFARCTION; INDUCED PROLONGATION; GENERAL-ANESTHESIA; RISK-FACTORS;
D O I
10.1097/CCM.0b013e3181de112a
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The objective of this review is to characterize the mechanisms, risk factors, and offending pharmacotherapeutic agents that may cause drug-induced arrhythmias in critically ill patients. PubMed, other databases, and citation review were used to identify relevant published literature. The authors independently selected studies based on relevance to the topic. Numerous drugs have the potential to cause drug-induced arrhythmias. Drugs commonly administered to critically ill patients are capable of precipitating arrhythmias and include antiarrhythmics, antianginals, antiemetics, gastrointestinal stimulants, antibacterials, narcotics, antipsychotics, inotropes, digoxin, anesthetic agents, bronchodilators, and drugs that cause electrolyte imbalances and bradyarrhythmias. Drug-induced arrhythmias are insidious but prevalent. Critically ill patients frequently experience drug-induced arrhythmias; however, enhanced appreciation for this adverse event has the potential to improve prevention, treatment, patient safety, and outcomes in this patient population. (Crit Care Med 2010; 38[Suppl.]:S188-S197)
引用
收藏
页码:S188 / S197
页数:10
相关论文
共 50 条
  • [31] Steepening of the slope of QT interval restitution is a risk factor for drug-induced arrhythmias
    Chauveau, S.
    Rahim, T.
    Jiang, Y.
    Coronel, R.
    Opthof, T.
    Janse, M.
    Anyukhovsky, Y.
    Cohen, I. S.
    Rosen, M. R.
    EUROPEAN HEART JOURNAL, 2014, 35 : 268 - 269
  • [32] Drug-induced long QT syndrome and fatal arrhythmias in the intensive care unit
    Beitland, S.
    Platou, E. S.
    Sunde, K.
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2014, 58 (03) : 266 - 272
  • [33] DRUG-INDUCED DISEASES - DRUG-INDUCED METABOLIC DISEASE
    RICHARDS, P
    BRITISH MEDICAL JOURNAL, 1979, 1 (6171): : 1128 - 1129
  • [34] Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death
    De Bruin, ML
    Pettersson, M
    Meyboom, RHB
    Hoes, AW
    Leufkens, HGM
    EUROPEAN HEART JOURNAL, 2005, 26 (06) : 590 - 597
  • [35] CELLULAR MECHANISM FOR VENTRICULAR ARRHYTHMIAS RELATED TO THE DRUG-INDUCED LONG QT SYNDROME
    BRACHMANN, J
    SCHERLAG, BJ
    HARRISON, L
    LAZZARA, R
    CLINICAL RESEARCH, 1982, 30 (02): : A175 - A175
  • [36] DRUG-INDUCED DISEASES - DRUG-INDUCED HEMATOLOGICAL DISEASE
    DAWSON, AA
    BRITISH MEDICAL JOURNAL, 1979, 1 (6172): : 1195 - 1197
  • [37] Do we understand the electrophysiologic mechanisms responsible for drug-induced cardiac arrhythmias?
    Vos, MA
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2002, 40 (05) : 647 - 650
  • [38] RYANODINE SUPPRESSES DRUG-INDUCED TRIGGERED ARRHYTHMIAS IN ISOLATED FERRET VENTRICULAR MUSCLE
    MARBAN, E
    WIER, WG
    CIRCULATION, 1985, 72 (04) : 380 - 380
  • [39] Dexmedetomidine reduces ventricular arrhythmias in a model of drug-induced QT-prolongation
    Frommeyer, G.
    Brandt, J.
    Ellermann, C.
    Wolfes, J.
    Eckardt, L.
    EUROPEAN HEART JOURNAL, 2020, 41 : 398 - 398
  • [40] Drug-Induced Hepatotoxicity or Drug-Induced Liver Injury
    Pugh, Aaron J.
    Barve, Ashutosh J.
    Falkner, Keith
    Patel, Mihir
    McClain, Craig J.
    CLINICS IN LIVER DISEASE, 2009, 13 (02) : 277 - +